| Literature DB >> 27885891 |
Jose Maria Bastida1, Monica Del Rey2, Nuria Revilla3, Rocio Benito2, Martin Perez-Andrés4, Berta González5, Susana Riesco6, Kamila Janusz2, Jose Padilla3, Ana Hortal Benito-Sendin6, David Bueno5, Elena Blanco3, Maria Hernández-Rivas1,2, Vicente Vicente3,7, Jose Rivera3,7, Ramon González-Porras1, Maria Luisa Lozano3,7.
Abstract
Wiskott-Aldrich syndrome (WAS) is a rare X-linked recessive disease resulting from variants in the WAS gene, characterized by a triad of immunodeficiency, eczema, and thrombocytopenia. Despite the fact that WAS is traditionally differentiated from immune thrombocytopenia (ITP) by small size of WAS platelets, in practice, microthrombocytopenia may occasionally not be present, and in certain cases, WAS patients exhibit some parallelism to ITP patients. We characterized one patient presenting with the classic form of the disease but increased mean platelet volume. Molecular studies revealed a novel hemizygous 1-bp deletion in WAS gene, c.802delC, leading to a frameshift and stop codon at amino acid 308 (p.Arg268Glyfs*40). Next-generation sequencing of a total of 70 additional genes known to harbor variants implicated in inherited platelet disorders did not identify additional defects. The pathogenesis of macrothrombocytopenia in this case is not known, but probably the coexistence of a still unidentified additional genetic variant might be involved.Entities:
Keywords: Genetic diagnosis; Wiskott–Aldrich syndrome; immune thrombocytopenia; inherited thrombocytopenia; next-generation sequencing
Mesh:
Year: 2016 PMID: 27885891 DOI: 10.1080/09537104.2016.1246715
Source DB: PubMed Journal: Platelets ISSN: 0953-7104 Impact factor: 3.862